The pioneering efforts in the development of therapeutic arteriogenesis for cerebral ischemia reported by Buschmann et al 1 herald a new era in the field of stroke therapy. The role of collaterals in maintaining perfusion beyond the site of a proximal arterial occlusion has long been appreciated as a critical factor in reducing ischemic injury in the brain, 2 analogous to observations in the coronary and peripheral circulation. Despite recent advances in therapeutic arteriogenesis of coronary and peripheral collaterals, studies of the cerebral collateral circulation have been limited.
Response
We very much appreciate Dr Liebeskind's letter. We fully agree that the collateral circulation in the brain is far more complex than in the peripheral vasculature. Indeed, in the first part of our study, we carefully characterized the response of the circle of Willis to 3-vessel occlusion (3-VO, ipsilateral carotid and bilateral vertebral artery ligation) both short term (1-week survival) and long term (3-week survival). These data were published 1 before our investigation on the therapeutic effects of granulocyte-macrophage colony-stimulating factor and actually deal with the questions raised by Dr Liebeskind.
We examined the diameter of the anterior and middle cerebral arteries, the internal carotid artery, and Heubner's dorsal leptomeningeal anastomoses after 1 and 3 weeks of 3-VO. We expected that arteriogenic growth would also take place in regions of smaller arteriolar connections, as described by Wei and coworkers 2 in rats after stroke. However, after 1 week, the only significant difference in vessel diameter was observed in the ipsilateral posterior cerebral artery (PCA). After 3 weeks, a significant increase in vessel size was also detected in the ipsilateral anterior cerebral artery and the contralateral PCA. At this time, the diameter of the ipsilateral PCA had increased significantly from 187Ϯ27 to 322Ϯ50 m (plus 72%), that of the contralateral PCA from 196Ϯ29 to 261Ϯ38 m (plus 33%), and that of the ipsilateral anterior cerebral artery from 251Ϯ37 to 322Ϯ42 m (plus 28%). Other supplying arteries did not change in diameter during the observation period. Heubner's leptomeningeal anatomoses did not change either; in control animals, the mean diameter was ipsi-and contralateral 37Ϯ4 m; after 3-VO, it was 38Ϯ2 m on the ipsilateral and 37Ϯ3 m on the contralateral side; and after granulocyte-macrophage colonystimulating factor treatment, it insignificantly changed on the ipsilateral side to 39Ϯ6 m and on the contralateral side to 36Ϯ4 m.
In summary, our study demonstrates that the basal cerebral arteries respond more to 3-VO than Heubner's dorsal leptomeningeal anastomoses, but this effect may be adequate to protect the brain against ischemia arising from vascular stenosis. Collateral growth is closely linked to the location of blood pressure gradients within the vascular system. Thus, any experimental brain ligation model can only partially reflect the complex pattern of brain arteriogenesis.
